The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Totally agree. I also came late to this share but it's still ridiculously undervalued. A tier 1 asset in the making where 1m oz sells for around $100m. This should not be sold at this stage but if it is it would be criminal to let it go for less than 30p a share.
Hang on TF - AM has painted all shareholders with the same brush. All the rubbish that we won't understand this and won't understand that. He has used this as an excuse to deliberately withhold information. It is ridiculous.
Agree CH - I am really nervous now that AM thinks he can go alone on this. The flaring permit will only be a temporary fix so higher production may not occur. Big money is required and this company just don't have it.
It could well be the person who approached AM and set up this deal ie the bond holders themselves. They know the value of this- they could buy up the company for a song.
If there is big buying this week and then more shorting and converting again then I think we have our answer.